Genetic associations with a fever after measles-containing vaccines
Children have elevated fever risk 1 to 2 weeks after the first dose of a measles-containing vaccine (MCV), which is likely affected by genetic, immunologic, and clinical factors. Fever after MCV is associated with febrile seizures, though may also be associated with higher measles antibody titers. T...
Main Authors: | Nicola P. Klein, Ousseny Zerbo, Kristin Goddard, Weiqi Wang, Alison E. Fohner, Amy Wiesner, Vida Shokoohi, John Coller, Karin Bok, Hayley A. Gans |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-06-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2020.1849520 |
Similar Items
-
Parental risk factors for fever in their children 7–10 days after the first dose of measles-containing vaccines
by: Ousseny Zerbo, et al.
Published: (2020-04-01) -
Identification and description of mumps cases in a non-outbreak setting and evaluation of the effectiveness of mumps-containing vaccines over time
by: Ousseny Zerbo, et al.
Published: (2020-12-01) -
Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study
by: The MMR-162 Study Group
Published: (2018-12-01) -
Field Test and Validation of the Multiplier Measles, Mumps, Rubella, and Varicella-Zoster Multiplexed Assay System in the Democratic Republic of the Congo by Using Dried Blood Spots
by: Stephen G. Higgins, et al.
Published: (2019-08-01) -
Immune response to co-administration of measles, mumps, and rubella (MMR), and yellow fever vaccines: a randomized non-inferiority trial among one-year-old children in Argentina
by: Carla Vizzotti, et al.
Published: (2023-03-01)